Johnson & Johnson reported more MedTech growth as its fourth-quarter results came in slightly ahead of the consensus forecast. Shares of JNJ were down more than 2% to $158.68 apiece in morning trading. MassDevice‘s MedTech 100 Index was down slightly. The New Brunswick, New Jersey-based company posted profits of $4.1 billion. That equals $1.70 per share on […]
Johnson & Johnson
The biggest stories from the 2024 J.P. Morgan Healthcare Conference
Some of the biggest names in medtech came together this week at the J.P. Morgan Healthcare Conference. They shared updates on financial progress, operational changes and new products, among other things. Medtronic shared details on plans to restore earnings power, while Abbott highlighted the success of its FreeStyle Libre system. Shockwave Medical outlined its plans […]
J&J’s Acclarent wins FDA nod for pediatric ear tube balloon dilation system
Johnson & Johnson MedTech unit Acclarent announced that it won a new FDA clearance for its Aera Eustachian tube balloon dilation system. While Acclarent still belongs to Johnson & Johnson, Integra Lifesciences is set to buy it for $275 million next year. While the completion of that deal awaits, the company cleared a regulatory hurdle […]
The top medtech trends of 2023
The top medtech trends of 2023 included innovations such as artificial intelligence, new GLP-1 weight loss drugs and some long-awaited medtech finally receiving regulatory nods. With health providers facing additional challenges on top of an ever-uncertain economic environment, medtech companies also made major readjustments: layoffs, spinoffs, reorganizations and much more. Here are the top stories […]
J&J’s Biosense Webster treats first patients in dual-energy AFib ablation trial
Johnson & Johnson’s Biosense Webster today announced the first completed patient cases in a study of its dual-energy ablation catheter. Biosense Webster designed the ThermoCool SmartTouch SF to deliver both radiofrequency (RF) and pulsed-field ablation (PFA) energy. The SmartPulse pivotal study evaluates the dual-energy system in the treatment of paroxysmal AFib. AFib ablation has become […]
Former J&J MedTech head Ashley McEvoy takes board role at consumer goods giant
Less than two months after announcing her departure from Johnson & Johnson MedTech, Ashley McEvoy has taken on a role on the board of Procter & Gamble. In October, the former EVP and worldwide chair at J&J MedTech announced her intention to leave the world’s second-largest medical device manufacturer. Tim Schmid took over the position […]
Integra LifeSciences to buy Johnson & Johnson’s Acclarent and its ENT tech
Integra LifeSciences announced today that it entered into a definitive agreement to acquire Acclarent from Johnson & Johnson MedTech. Acclarent, part of J&J MedTech’s Ethicon unit, enhances Integra’s position in the ear, nose and throat (ENT) treatment market. Integra already offers the MicroFrance line of ENT instruments. The company believes that, upon closing, the deal […]
Johnson & Johnson’s Ethicon settles more Physiomesh suits
Johnson & Johnson has settled more than 200 cases remaining in a multi-district litigation over hernia mesh made by its Ethicon subsidiary. U.S. District Court Judge Richard Story in Northern Georgia on Dec. 1 agreed to dismiss the cases with prejudice at the request of lawyers for both sides. The lawyers had informed him that […]
Johnson & Johnson MedTech says new products will fuel growth
Johnson & Johnson considers itself “uniquely positioned to lead the next wave of healthcare innovation.” Ahead of a meeting with the investment community today, the company outlined its views on where it stands in the medtech and pharmaceutical markets. New Brunswick, New Jersey-based Johnson & Johnson set long-term financial targets, including at least 3% sales […]
Johnson & Johnson MedTech enters LAA device space with acquisition of Laminar
Johnson & Johnson MedTech announced today that it completed the acquisition of left atrial appendage (LAA) device maker Laminar. The deal, which includes a $400 million upfront payment, adds Johnson & Johnson MedTech to the crowded LAA device space. Established devices like Abbott’s Amplatzer Amulet and Boston Scientific’s Watchman already exist within the market. Medtronic […]
Ethicon unveils hemostatic sealing patch in Europe
Johnson & Johnson MedTech’s Ethicon today announced the European approval and introduction of Ethizia, its hemostatic sealing patch. The adjunctive hemostat solution helps to achieve sustained hemostasis in difficult to control bleeding situations. Ethizia features unique synthetic polymer technology for maximum adaptability. Ethicon said it’s the first and only hemostatic matrix designed to be equally […]